Delivery Order SPE2DB22D2006-SPE2DB25FW0RR

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,093.20 and a period of performance through April 3, 2025. It is a delivery order contract with a firm fixed price pricing type. The contract provides for the delivery of Celecoxib 200mg tablets, a pharmaceutical product, to support federal healthcare programs....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,298.08 firm fixed-price delivery order is for the supply of 4,565,092,057 Celecoxib 200 mg capsules. The contract has a period of performance through July 10, 2024 and does not include a set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $3,558.17, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4,565,938,793 units of Celecoxib 100 mg capsules, a pharmaceutical product, to support various government healthcare programs and federal facilities. This award is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major Defense agency, to Amerisourcebergen Drug Corp, a prominent pharmaceutical distributor. The $3,512.73 Firm Fixed Price Delivery Order is for the supply of 100 capsules of the prescription drug Celebrex 200 mg. The contract has a completion date of December 13, 2023 and is not designated as a set-aside award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $92,160.30 firm-fixed-price delivery order is for the supply of 4,538,530,427 units of the medication Celebrex 100mg. The contract has a period of performance through July 31, 2017. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,674.63, is for the delivery of Celebrex 200 mg capsules to support military healthcare programs. It is a firm-fixed price delivery order contract with a completion date of June 4, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award with ID SPE2DX15D6028|B456 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $303,759.00 firm-fixed-price delivery order is for the medical supply Celecoxib 200mg, a pharmaceutical product. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The $168,352.87 firm fixed-price delivery order contract is for the delivery of CELEBREX 200MG 100S, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, with ID SPE2DX15D6028|B392, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $101,540.05 firm fixed-price delivery order is for the supply of Celebrex 200mg medication. No set-aside was used for this award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, identified as SPE2DX15D6028|K445, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $150,011.43 firm fixed-price delivery order is for the supply of CELEBREX 200MG 100S medication, with a completion date of January 5, 2017. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FW0RR
    Delivery Order

This federal contract award, valued at $1,441.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,174,033 units of the medication Celecoxib 200 mg capsule, with a completion date of May 8, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This prime contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

The contract award is not designated as a set-aside, indicating open competition. No subcontractor information is provided. This contract award is part of Amerisourcebergen's broader portfolio of federal contract work, leveraging its expertise and capacity to fulfill diverse pharmaceutical and medical supply requirements for the U.S. government.

Generated 8/6/25, 10:03 AM